We bring together a wealth of expertise built on the experience of the Liverpool Trials Collaborative which has held full registration status with the UK Clinical Research Collaboration CTU network since its establishment in 2007.Read more about us
We have more than twenty years’ experience of delivering high impact cancer clinical trials, from early phase single centre studies to large multi-national pivotal trials that have improved outcomes for patients with cancer.
Paediatric, foetal and maternal health
Paediatric trials require specialist understanding. We have a 15 year track record for the design and conduct of successful paediatric national and international clinical trials that impact how children are treated.
The aim of our surgical portfolio is to improve the outcomes for surgical patients.
Our clinical specialties portfolio allows us to be responsive to local and national health needs and priorities. It includes cardiovascular and infection.
COVID Cancer Trial
The LCTC are managing a new project to assess the impact of COVID-19 on people with cancer.
LCTC to collaborate on a new NIHR funded neurological trial
LCTC has been awarded funding to collaborate on a new large NIHR funded trial in the prevention and treatment of seizures.
LCTC Chief Investigator, Professor Calum Semple, awarded OBE for COVID-19 efforts
The University of Liverpool’s Professor Calum Semple has been recognised with an OBE.
Increasing calls for transparency, reproducibility and data sharing within clinical trials have led to a greater emphasis on the early development and publication of well written Statistical Analysis Plans (SAPs).
To address a variation in practice a minimum set of items for SAPs was agreed with funders, regulatory authorities, journals and researchers. A downloadable version of the SAP checklist is available here.